Explore Stanford technologies available for licensing:

Researchers at Stanford have developed a mammalian-cell-based directed evolution platform that combines programmable RNA editing with viral-mediated recombination to enable iterative diversification and optimization of protein and nucleic acid sequences.

Stanford researchers have developed a novel class of fluorescent RNA-selective "RiboLight" dyes which enables bright, covalent, and highly specific labeling of RNA without DNA interference, delivering superior performance for imaging and quantification applications.

Stanford researchers have developed a new class of aryl ester RNA-reactive reagents that are stable for months in water yet rapidly modify RNA upon catalytic activation, enabling reliable, scalable tools for RNA research and therapeutic applications.

Stanford researchers have developed a method for screening RNA-modulating drugs that reports on changes to mRNA in its native cellular context.

A new deep-learning system called Atomic Rotationally Equivariant Scorer (ARES) significantly improves the prediction of RNA structures over previous artificial intelligence (AI) models.

Stanford researchers have developed a method to suppress immune responses to RNA therapy by chemically treating the RNA with an acylating reagent.

Researchers at Stanford have developed light-cleavable cloaking agents to control and study RNA activity in vitro and in vivo.

Stanford researchers in Professor Rhiju Das's lab have devised a method called RNAMake to optimize nucleic acids, such as aptamers and messenger RNAs, and enhance their effectiveness for clinical settings.